PegIntron and Rebetol (peginterferon alfa-2b and ribavirin)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- March 2008
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.|
- The adverse event profile in Study 3...
- The most serious possible side effects of Peglntron and PegIntron/Rebetol therapy include:
- Body Organ Problems
- Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Label not available on Drugs@FDA